- 全部删除
- 您的购物车当前为空
Droxidopa (L-DOPS)是一种有效的口服活性去甲肾上腺素前体,能透过血脑屏障。Droxidopa 可增加站立血压,改善体位性低血压症状并提高站立能力,常用于研究神经源性体位性低血压(nOH)和替代性多动症 (注意缺陷多动障碍)等疾病 。
Droxidopa (L-DOPS)是一种有效的口服活性去甲肾上腺素前体,能透过血脑屏障。Droxidopa 可增加站立血压,改善体位性低血压症状并提高站立能力,常用于研究神经源性体位性低血压(nOH)和替代性多动症 (注意缺陷多动障碍)等疾病 。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 223 | In stock | |
5 mg | ¥ 512 | In stock | |
10 mg | ¥ 748 | In stock | |
25 mg | ¥ 1,250 | In stock | |
50 mg | ¥ 1,850 | In stock | |
100 mg | ¥ 2,780 | In stock |
Droxidopa 相关产品
产品描述 | Droxidopa (L-DOPS) is an effective orally active norepinephrine precursor capable of crossing the blood-brain barrier. It can increase standing blood pressure, improve symptoms of orthostatic hypotension, and enhance standing ability. Droxidopa is commonly used in studies of neurogenic orthostatic hypotension (nOH) and alternative treatments for attention-deficit/hyperactivity disorder (ADHD). |
体内活性 | Droxidopa通过口服给药,吸收后通过酶多巴脱羧酶转化为去甲肾上腺素,与内源性去甲肾上腺素共同增加神经递质水平。Droxidopa也可以穿过血脑屏障(BBB),并在脑内转化为去甲肾上腺素和肾上腺素。 |
别名 | 屈昔多巴, 屈西多巴, SM5688, L-DOPS, DOPS |
分子量 | 213.19 |
分子式 | C9H11NO5 |
CAS No. | 23651-95-8 |
Smiles | N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O |
密度 | 1.608g/cm3 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 2.13 mg/ml (10 mM), Sonication is recommended. ![]() H2O: 1.25 mM, Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容